semaglutide constipation lawsuit in west virginia glp-1 nausea law firm office Nutritional priorities to support therapy for obesity: GLP-1 west virginia glp-1 vomiting lawsuit

FDA-approved GLP-1 receptor agonists include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin), exenatide (Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist

semaglutide 2.4 mg had a significant impact on the appetite and eating habits of adults with obesity

That way you have it in front of you

Wegovy has the active ingredient Semaglutide which mimics a hormone called Glucagon like Peptide-1 (GLP-1)

Rarely reported side effects include: Allergic reactions, leading to a rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, and trouble breathing